MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-CH-01-0016176
Raymed Pharmaceuticals Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.9 Cr
▼ 2% YoY
Net profit · FY 2025
₹89.8 Lakh
Net margin 6%
EBITDA · FY 2025
₹2.18 Cr
EBITDA margin 14.6%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹17.07 Lakh
Issued & subscribed
Open charges
₹4.46 Cr
Satisfied ₹86.6 Lakh
Company age
31 yrs
Est. 1995
Employees · EPFO
8
Provident fund records
About Raymed Pharmaceuticals Limited
Data last updated:
Raymed Pharmaceuticals Limited is a public limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 January 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231CH1995PLC015598. Its GSTIN is 04AACCR6935L1Z4 (Chandigarh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹17.07 Lakh. It is led by directors including Tarsem Kumar Ruby and Veeta Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 859 Manimajra Chandigarh, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.9 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹89.8 Lakh (net margin 6%) and EBITDA of ₹2.18 Cr (EBITDA margin 14.6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.46 Cr and satisfied charges of ₹86.6 Lakh on record. Court records list 2 cases involving the company, including 2 filed by the company; 1 case is pending.
Raymed Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0016176). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website raymedindia.com.
Company details
CIN U24231CH1995PLC015598
Registration Number 015598
Incorporation Date 10 January 1995
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-CH-01-0016176
CIN history
Raymed Pharmaceuticals has one previous CIN (Corporate Identification Number): L24231CH1995PLC015598. The current CIN is U24231CH1995PLC015598, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231CH1995PLC015598 | Current |
| L24231CH1995PLC015598 | Previous |
Recognitions & Rankings of Raymed Pharmaceuticals
Contact details
Raymed Pharmaceuticals Limited's registered office is in Chandigarh, Chandigarh. Its website is raymedindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address859 Manimajra Chandigarh, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Raymed Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Raymed Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Raymed Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Raymed Pharmaceuticals Limited, buy the company report.
Financials of Raymed Pharmaceuticals Limited
FY 2024 filings availableRaymed Pharmaceuticals Limited reported revenue of ₹14.9 Cr (down 2% YoY) for FY 2025.
Revenue · FY 2025
₹14.9 Cr ▼ 2%
Net profit · FY 2025
₹89.8 Lakh margin 6%
EBITDA · FY 2025
₹2.18 Cr margin 14.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 25%
3 years · compounded
▲ 22%
5 years · compounded
▲ 1%
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹89.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.6% | ||||
| Net Profit Margin | 6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raymed Pharmaceuticals Limited, buy the company report.
Board of directors of Raymed Pharmaceuticals Limited
Raymed Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tarsem Kumar Ruby Also directs: Raycure Drugs Limited, Raymed Ophthalmic Private Limited, Raymzon Trade Links Private Limited and 4 more | Director | 10 Jan 1995 | 31 Years 9 Months | Current |
| Veeta Sharma Also directs: Raycure Drugs Limited, Raymzon Trade Links Private Limited, Raymazon Pharmalinks Private Limited and 1 more | Director | 30 Mar 1997 | 29 Years 6 Months | Current |
| Shivansh Sharma Also directs: Raymed Ophthalmic Private Limited, Raymzon Trade Links Private Limited, Aquavision Pharmaceuticals Private Limited and 2 more | Director | 17 Apr 2015 | 11 Years 6 Months | Current |
Peer comparison
Raymed Pharmaceuticals Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kansas Laboratories Pvt Ltd | ₹15.04 Cr (FY 2025) | 13.0% | Kolkata, West Bengal, India | |||
| Grindlays Pharmaceuticals Pvt Ltd | ₹14.96 Cr (FY 2025) | 69.0% | Mumbai, Maharashtra, India | |||
| Santexo Pharma Private Limited | ₹14.95 Cr (FY 2025) | 86.0% | New Delhi, Delhi, India | |||
| Revive Formulations India Private Limited | ₹14.93 Cr (FY 2024) | 5.0% | Vanur, Tamil Nadu, India | |||
| Theo Pharma Pvt Ltd | ₹14.91 Cr (FY 2025) | 26.0% | Ahmedabad, Gujarat, India | |||
| Raymed Pharmaceuticals Limitedthis company | ₹14.9 Cr (FY 2025) | ₹89.8 Lakh | 6% | -2.0% | 8 | Chandigarh, India |
| Beref Pharmaceuticals Private Limited | ₹14.86 Cr (FY 2025) | 36.0% | Chennai, Tamil Nadu, India | |||
| Kureasia Pharma Private Limited | ₹14.86 Cr (FY 2024) | 56.0% | New Delhi, Delhi, India |
To see the full peer comparison of Raymed Pharmaceuticals Limited, buy the company report.
Auditor
Raymed Pharmaceuticals Limited is audited by ATUL CHOPRA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL CHOPRA & CO. | FY 2023 | 012289N |
Shareholding
The shareholding of Raymed Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Raymed Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹4.46 Cr
Satisfied charges
₹86.6 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Aug 2023 | 100781239 | Axis Bank Limited | ₹60 Lakh | Open | |
| 19 Jun 2023 | 100770796 | Hdfc Bank Limited | ₹80 Lakh | Open | |
| 26 Dec 2022 | 100669059 | Hdfc Bank Limited | ₹3 Cr | Open | |
| 08 Nov 2004 | 90170040 | Union Bank of India | ₹6 Lakh | Open | |
| 23 Dec 2004 | 90170068 | Union Bank of India | ₹1.6 Lakh | Satisfied |
To see the full charge records of Raymed Pharmaceuticals Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Raymed Pharmaceuticals Limited has 2 court cases on record: 2 filed by Raymed Pharmaceuticals. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
To see the full case history of Raymed Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Raymed Pharmaceuticals Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 9 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Hanuchem Laboratories | |||
| Lenus Life Care Private Limited | |||
| Elnova Pharma | |||
| Medivisual Healthworld | |||
| Perennial Medicare |
To see the full MSME payment records of Raymed Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Raymed Pharmaceuticals Limited has a workforce of 8 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
8
Active EPFO establishments
1
Employee growth
-33.33%
GST
Raymed Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AACCR6935L1Z4 | Chandigarh | Active | 01 Jul 2017 |
| 06AACCR6935L1Z0 | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Raymed Pharmaceuticals Limited, buy the company report.
Recent activity
Raymed Pharmaceuticals Limited has 6 board changes on record since 1995: 3 appointments and 3 cessations. The latest: Sanjay Jhamb ceased to be Director on 06 Dec 2022.
AGM
Raymed Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Raymed Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited of Rs. 3.00 Cr registered on 26 Dec 2022 with Charge ID 100669059 was modified on 12 Mar 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.60 Cr with Charge ID 100781239 was registered on 30 Aug 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.80 Cr with Charge ID 100770796 was registered on 19 Jun 2023.
Charges
A charge registered on 23 Dec 2004 via Charge ID 90170068 with Union Bank Of India was fully satisfied on 05 Apr 2023.
Charges
A charge registered on 12 Jan 2004 via Charge ID 90169891 with Union Bank Of India was fully satisfied on 05 Apr 2023.
Charges
A charge registered on 08 Nov 2002 via Charge ID 90169723 with Union Bank Of India was fully satisfied on 05 Apr 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.00 Cr with Charge ID 100669059 was registered on 26 Dec 2022.
Ceased
Sanjay Jhamb ceased to be Director.
Ceased
Sat Parkash Mittal ceased to be Director.
Ceased
Shivansh Sharma ceased to be Additional Director.
10 earlier events are in the company report.
Frequently asked questions
Raymed Pharmaceuticals is an active public limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 January 1995 (31+ years old) and is registered under CIN U24231CH1995PLC015598.
Raymed Pharmaceuticals has 3 current directors:
- Tarsem Kumar Ruby - Director
- Veeta Sharma - Director
- Shivansh Sharma - Director
The latest financial statements of Raymed Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Raymed Pharmaceuticals is 04AACCR6935L1Z4, registered in Chandigarh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AACCR6935L1Z0 (Haryana).
The CIN (Corporate Identification Number) of Raymed Pharmaceuticals is U24231CH1995PLC015598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raymed Pharmaceuticals has 2 court cases on record: 2 filed by the company. 1 is pending.
Raymed Pharmaceuticals was incorporated on 10 January 1995, making it 31+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Raymed Pharmaceuticals by revenue are Kansas Laboratories Pvt Ltd, Grindlays Pharmaceuticals Pvt Ltd, Santexo Pharma Private Limited, Revive Formulations India Private Limited, Theo Pharma Pvt Ltd and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sanjay Jhamb ceased to be Director on 06 Dec 2022. Sat Parkash Mittal ceased to be Director on 31 Aug 2020. Shivansh Sharma ceased to be Additional Director on 25 Sep 2015. Raymed Pharmaceuticals has 6 board changes on record in total.
Yes, Raymed Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0016176).
Raymed Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 9 overdue payments to 5 micro and small suppliers. The latest return was filed on 09 Jun 2019.
Raymed Pharmaceuticals can be reached through the website raymedindia.com. Its registered office is in Chandigarh, India.